Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften E-learning Web-tv Video Audio
Tips voor Mijn BSL
UITGEBREID ZOEKEN
Inloggen
Top
Quality of Life Research
Gepubliceerd in: Quality of Life Research 9/2011

01-11-2011 | Brief Communication

Factors associated with quality of life in hemifacial spasm and blepharospasm during long-term treatment with botulinum toxin

Auteurs: Suwanna Setthawatcharawanich, Pornchai Sathirapanya, Kitti Limapichat, Kanitpong Phabphal

Gepubliceerd in: Quality of Life Research | Uitgave 9/2011

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

Purpose

This study was undertaken to assess the impact of hemifacial spasm (HFS) and blepharospasm (BS) on quality of life (QOL) during long-term treatment with botulinum toxin injections.

Methods

Fifty-three patients with HFS and 32 patients with BS as well as two healthy age- and sex-matched control groups were included in the study. All participants independently completed the disease-specific questionnaire for QOL, the HFS-30, and the Thai Depression Inventory, and also provided a peak improvement score assessment.

Results

The disease severity in both patient groups revealed mild functional impairment. The scores of HFS-30 in HFS patients (four of 8 subscales) and BS patients (3 of 8 subscales) were significantly higher than the control groups. In both HFS and BS, depression scores were positively correlated with the HFS-30 scores, while peak improvement and educational level were inversely correlated with the HFS-30 scores. Patients with BS were more affected in Mobility and Activities of Daily Living than HFS patients.

Conclusions

Both HFS and BS affect QOL both physically and mentally despite clinical improvement with botulinum toxin. Depression and peak improvement after injection were associated with the level of QOL.
vorige artikel Examining the ability to detect change using the TRIM-Diabetes and TRIM-Diabetes Device measures
volgende artikel An appreciation of Dr. Stephen M. Haley, PT, PhD, FAPTA
Literatuur
1.
Wang, A., & Jankovic, J. (1998). Hemifacial spasm: Clinical findings and treatment. Muscle and Nerve, 21(12), 1740–1747.PubMedCrossRef
2.
Hallett, M. (2002). Blepharospasm: Recent advances. Neurology, 59(9), 1306–1312.PubMed
3.
Setthawatcharawanich, S., & Ovartlanporn, S. (2007). Effective treatment of hemifacial spasm and blepharospasm with botulinum toxin type A in Songklanagarind Hospital. Songkla Medical Journal, 25(3), 191–199.
4.
Jitpimolmard, S., Tiamkao, S., & Laopaiboon, M. (1998). Long term results of botulinum toxin type A (Dysport) in the treatment of hemifacial spasm: A report of 175 cases. Journal of Neurology, Neurosurgery and Psychiatry, 64(6), 751–757.CrossRef
5.
Poungvarin, N., Devahastin, V., Chaisevikul, R., Prayoonwiwat, N., & Viriyavejakul, A. (1997). Botulinum A toxin treatment for blepharospasm and Meige syndrome: Report of 100 patients. Journal of Medical Association of Thai, 80(1), 1–8.
6.
Muller, J., Kemmler, G., Wissel, J., Schneider, A., Voller, B., Grossmann, J., et al. (2002). The impact of blepharospasm and cervical dystonia on health-related quality of life and depression. Journal of Neurology, 249(7), 842–846.PubMedCrossRef
7.
MacAndie, K., & Kemp, E. (2004). Impact on quality of life of botulinum toxin treatments for essential blepharospasm. Orbit, 23(4), 207–210.PubMedCrossRef
8.
Ochudlo, S., Bryniarski, P., & Opala, G. (2007). Botulinum toxin improves the quality of life and reduces the intensification of depressive symptoms in patients with blepharospasm. Parkinsonism Related Disorders, 13(8), 505–508.PubMedCrossRef
9.
Tan, E. K., Fook-Chong, S., Lum, S. Y., & Lim, E. (2004). Botulinum toxin improves quality of life in hemifacial spasm: Validation of a questionnaire (HFS-30). Journal of the Neurological Sciences, 219(1-2), 151–155.PubMedCrossRef
10.
Setthawatcharawanich, S., Aui-aree, N., Limapichart, K., Satirapunya, P., & Phabphal, K. (2008). The validation of the disease-specific questionnaire for health-related quality of life in Thai patients with hemifacial spasm. Journal of Medical Association of Thai, 91(11), 1691–1697.
11.
Hall, T. A., McGwin, G., Searcey, K., Xie, A., Hupp, S. L., Owsley, C., et al. (2006). Health-related quality of life and psychosocial characteristics of patients with benign essential blepharospasm. Archives of Ophthalmology, 124(1), 116–119.PubMedCrossRef
12.
Reimer, J., Gilg, K., Karow, A., Esser, J., & Franke, G. H. (2005). Health-related quality of life in blepharospasm or hemifacial spasm. Acta Neurologica Scandinavica, 111(1), 64–70.PubMedCrossRef
13.
Mangione, C. M., Lee, P. P., Gutierrez, P. R., Spritzer, K., Berry, S., & Hays, R. D. (2001). Development of the 25-item National Eye Institute Visual Function Questionnaire. Archives of Ophthalmology, 119(7), 1050–1058.PubMed
14.
Jankovic, J., Schwartz, K., & Donovan, D. T. (1990). Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm. Journal of Neurology, Neurosurgery and Psychiatry, 53(8), 633–639.CrossRef
15.
Lindeboom, R., De Haan, R., Aramideh, M., & Speelman, J. D. (1995). The blepharospasm disability scale: An instrument for the assessment of functional health in blepharospasm. Movement Disorders, 10(4), 444–449.PubMedCrossRef
16.
Lotrakul, M., & Sukanich, P. (1999). Development of the Thai depression inventory. Journal of Medical Association of Thai, 82(12), 1200–1207.
17.
Setthawatcharawanich, S., Aui-aree, N., Sathirapanya, P., Plabparn, K., & Limapichart, K. (2009). The validation of the disease-specific questionnaire for health related quality of life in Thai patients with blepharospasm. Songkla Medical Journal, 27(3), 249–257.
18.
Tan, E. K., Hameed, S., Fook-Chong, S., Hussein, K., Lum, S. Y., & Chan, L. L. (2008). Treatment outcome correlates with knowledge of disease in hemifacial spasm. Clinical Neurology and Neurosurgery, 110(8), 813–817.PubMedCrossRef
Metagegevens
Titel
Factors associated with quality of life in hemifacial spasm and blepharospasm during long-term treatment with botulinum toxin
Auteurs
Suwanna Setthawatcharawanich
Pornchai Sathirapanya
Kitti Limapichat
Kanitpong Phabphal
Publicatiedatum
01-11-2011
Uitgeverij
Springer Netherlands
Gepubliceerd in
Quality of Life Research / Uitgave 9/2011
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-011-9890-y

Andere artikelen Uitgave 9/2011

Quality of Life Research 9/2011 Naar de uitgave

OriginalPaper

Using the knee-specific Hughston Clinic Questionnaire, EQ-5D and SF-6D following arthroscopic partial meniscectomy surgery: a comparison of psychometric properties

OriginalPaper

Measuring health and well-being effects in family caregivers of children with craniofacial malformations

OriginalPaper

A comparison of the discriminative and evaluative properties of the SF-36 and the SF-6D index

OriginalPaper

Quality of life and its correlates in caregivers of stroke survivors from a Nigerian population

Brief Communication

Measuring quality of life in low-income, Spanish-speaking Puerto Ricans with type 2 diabetes residing in the mainland U.S.

OriginalPaper

Using the PedsQL™ 3.0 asthma module to obtain scores comparable with those of the PROMIS pediatric asthma impact scale (PAIS)